XOMA Corporation (XOMAP)
25.32
-0.18 (-0.71%)
At close: Jan 14, 2025, 9:00 PM
undefined% (undefined)
| Bid | 25.3 |
| Market Cap | 298.34M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 1.001 |
| PE Ratio (ttm) | 25.29 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 25.74 |
| Volume | 507 |
| Avg. Volume (20D) | 1,332 |
| Open | 25.32 |
| Previous Close | 25.50 |
| Day's Range | 25.32 - 25.32 |
| 52-Week Range | 24.61 - 26.51 |
| Beta | undefined |
About XOMAP
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with ...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 16, 2020
Employees 13
Stock Exchange NASDAQ
Ticker Symbol XOMAP
Website https://www.xoma.com